Riskpilot← Back to searchSign inGet full accessHEARTS & SCIENCE AS
ASActiveOrg 921373473Frøyas gate 15, 0273 OsloMedia representation · NACE 7312Est. 20180 employees
Revenue 2024
NOK 6,4M
+2840% vs 2023
EBITDA margin
25.1%
+909% vs 2023
Equity ratio
28.3%
Financial strength
Net profit 2024
NOK 1,4M
+2527% vs 2023
| Revenue | NOK 6,4M | +2840% |
| EBITDA | NOK 1,6M | +909% |
| Net profit | NOK 1,4M | +2527% |
| Total assets | NOK 12,9M | +43% |
| Equity | NOK 3,7M | +66% |
| Employees | 0 | — |
Legal name
HEARTS & SCIENCE AS
Org number
921373473
Legal form
Aksjeselskap
NACE code
7312 · Media representation
Founded
10. september 2018
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Enten selv eller gjennom hel- eller deleide selskaper, eller gjennom samarbeid med andre selskaper å inngå avtaler og drive virksomhet knyttet til medier og mediebransjen samt delta i annen lignende virksomhet.
Address
Frøyas gate 15, 0273 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 146 108 | 94 567 | 7 483 | 219 | 6 438 |
| Staff expenses | −4 251 | −1 918 | −918 | −11 | −209 |
| EBITDA | 543 | 1 097 | 90 | −200 | 1 618 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 543 | 1 097 | 90 | −200 | 1 618 |
| Net financials | 155 | 120 | 454 | 271 | 235 |
| Profit before tax | 697 | 1 218 | 543 | 71 | 1 853 |
| Tax | 153 | 268 | 119 | 16 | 408 |
| Net profit | 544 | 950 | 424 | 55 | 1 445 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 49 509 | 62 242 | 52 078 | 9 063 | 12 919 |
| Equity | 776 | 1 726 | 2 150 | 2 205 | 3 650 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 48 733 | 60 516 | 49 929 | 6 858 | 9 268 |
| Total debt | 48 733 | 60 516 | 49 929 | 6 858 | 9 268 |
EBITDA margin
25.1%
This company
15.8%
Market median
+59% vs market
20202024
Equity ratio
28.3%
This company
38.2%
Market median
-26% vs market
20202024
Return on equity
39.6%
This company
18.4%
Market median
+115% vs market
20202024
Net profit margin
22.4%
This company
8.1%
Market median
+177% vs market
20202024
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20202024
Debt / equity
2.54×
This company
0.62×
Market median
-310% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EK Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Omnicom Media Group As
HEARTS & SCIENCE AS Board members of HEARTS & SCIENCE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Espen Klepper | Chief Executive Officer | 0 companies |
| Rune Kristiansen | Board of Directors | 0 companies |